微体质前列腺素e2合成酶-1调节了对血管损伤的反应
Miao Wang1, Kaori Ihida-Stansbury, Devashish Kothapalli
1Institute for Translational Medicine and Therapeutics, Department of Pharmacology, University of Pennsylvania, Philadelphia, USA. miaowang@upenn.edu
Circulation
|February 2, 2011
概括
向微小的前列腺素E合成酶-1 (mPGES-1) 通过调节素-C来减少血管损伤和增生. 这表明mPGES-1抑制剂可能有助于穿皮冠状动脉干预治疗.
科学领域:
- 生物医学科学 生物医学科学
- 心血管研究研究心血管研究
- 炎症和免疫学 炎症和免疫学
背景情况:
- 微粒体前列腺素E合成酶-1 (mPGES-1) 产生前列腺素E2 (PGE2).
- 抑制mPGES-1可能为COX-2抑制剂提供更安全的替代品,避免高血压和血栓形成.
- 删除mPGES-1已经显示出对动脉样硬化和大动脉动脉瘤形成的保护作用.
研究的目的:
- 研究mPGES-1在血管损伤反应中的作用.
- 为了确定mPGES-1删除对新极端增生症的影响.
- 探索涉及田素-C和前列腺素生产的潜在机制.
主要方法:
- 在mPGES-1淘汰赛和野生型小鼠中,大腿动脉的电线损伤模型.
- 测量新极端区域和血管狭窄的量化.
- 在血管组织和细胞中分析素-C表达和前列腺素 (PGE2,PGI2) 生物合成.
主要成果:
- mPGES-1淘汰赛小鼠在受伤后表现出显著减少的neointimal区域和血管狭窄.
- 在受伤后的特纳辛-C诱导在mPGES-1淘汰赛小鼠中被减弱.
- 缺乏mPGES-1的血管光滑肌细胞产生较少的PGE2和更多的PGI2,抑制增殖和迁移.
结论:
- mPGES-1 缺失减轻了血管损伤后的新极度增生症.
- 这种机制涉及到调节tenascin-C表达的机制.
- mPGES-1 抑制剂是穿皮冠状动脉干预的潜在辅助疗法.
更多相关视频
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:30Inflammatory Response I: Vascular and Cellular
15.8K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.8K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:16Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
01:28Inflammatory Response
12.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.5K
01:25Acute Inflammation II: Local and Systemic Effects
56
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56